After asthma treatment, if a patient has an FEV1 less than 40% of personal best, what is the recommended action?

After asthma treatment, if a patient has an FEV1 less than 40% of personal best, what is the recommended action?

• A. Continue current plan
• B. Hospitalization for urgent care
• C. Seek emergency department for evaluation
• D. Administer only SABA at home

Answer: (C)

A key safety signal in asthma management is a sudden, large drop in lung function relative to the patient’s personal best after treatment. If FEV1 falls below 40% of that personal best, it indicates a severe or potentially life‑threatening exacerbation that must be evaluated urgently in a medical setting. The recommended action is to seek care in the emergency department promptly. There, clinicians can reassess airway obstruction, check oxygenation, and escalate therapy quickly—such as giving higher-dose bronchodilators, systemic steroids, and oxygen as needed, with ongoing monitoring and the option for admission if the patient does not improve. This scenario is not safely managed at home, and simply continuing the current plan or administering only a short-acting bronchodilator at home would not address the severity. Hospital admission may be needed, but the critical first step is ED evaluation to determine the appropriate level of care.

A key safety signal in asthma management is a sudden, large drop in lung function relative to the patient’s personal best after treatment. If FEV1 falls below 40% of that personal best, it indicates a severe or potentially life‑threatening exacerbation that must be evaluated urgently in a medical setting.

The recommended action is to seek care in the emergency department promptly. There, clinicians can reassess airway obstruction, check oxygenation, and escalate therapy quickly—such as giving higher-dose bronchodilators, systemic steroids, and oxygen as needed, with ongoing monitoring and the option for admission if the patient does not improve. This scenario is not safely managed at home, and simply continuing the current plan or administering only a short-acting bronchodilator at home would not address the severity. Hospital admission may be needed, but the critical first step is ED evaluation to determine the appropriate level of care.